FDA Adverse Event Injury Summary report: N

FLEXTEND

MDR report key: 3040662 · Received April 8, 2013

Report

Report Number
2124215-2013-00172
Event Type
Injury
Date Received
April 8, 2013
Date of Event
January 3, 2013
Report Date
January 15, 2013
Manufacturer
CPI - DEL CARIBE
Product Code
NVN
PMA / PMN Number
P960006
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

Narratives

Additional Manufacturer Narrative · 1

AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THE RIGHT VENTRICULAR (RV) LEAD HAD TRIPPED THE LEAD SAFETY SWITCH DUE TO IMPEDANCE MEASUREMENTS GREATER THAN 2000 OHMS. WHILE INVESTIGATING, IT WAS NOTED THAT VENTRICULAR TACHYCARDIA (VT) EPISODES WERE STORED DUE TO NOISE. WHEN TELEMETRY WAS REMOVED, THE NOISE PERSISTED; HOWEVER, ONLY OCCURED IN BIPOLAR CONFIGURATION. THE PATIENT WAS NOT PACEMAKER DEPENDENT AND HAD NO SYMPTOMS. WHEN THE MINUTE VENTILATION WAS PROGRAMMED OFF, THE NOISE RESOLVED. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Description of Event or Problem · 1

SUBSEQUENT INFORMATION WAS RECEIVED THAT TH POCKET WAS OPENED AND VISUAL CHECK OF THE LEAD CONFIRMED THAT THE LEAD WAS FULLY INSERTED INTO THE DEVICE. UPON REMOVAL OF THE LEAD FROM THE HEADER, DRIED BLOOD WAS NOTED ON BOTH THE TERMINAL PIN AND RING ELECTRODE AS WELL AS IN THE RV PORT. THE LEAD WAS THOROUGHLY CLEANED AND THE PORT WAS FLUSHED. ALL TESTING CONFIRMED NORMAL FUNCTION. THE SYSTEM REMAINS IMPLANTED AS THE PHYSICIAN BELIEVED THE CLINICAL OBSERVATIONS WERE A RESULT OF THE BLOOD INFILTRATION, WHICH WAS REMOVED. NO ADVERSE PATIENT EFFECTS WERE REPORTED AS A RESULT OF THE PROCEDURE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
142774 FLEXTEND IMPLANTABLE LEAD NVN CPI - DEL CARIBE 4088

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention